Breast cancer trial with erythropoietin terminated unexpectedly.
Leyland-Jones
Brian
B
McGill University, Montreal, Canada.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D015996:Survival Rate
D011994:Recombinant Proteins; D004921:Erythropoietin